President Trump is expected to make another effort to cut drug prices significantly by binding the government’s costs for certain medicines to reduced prices in other countries.
Mr. Trump early next week is reportedly scheduled to sign an executive order instructing administration officials to build a Most Favored Nation (MFN) drug pricing initiative for a range of drugs that Medicare would cover.

The MFN Model would limit how much Medicare spends on certain high-cost drugs based on the drug’s lowest price in other wealthy countries.

The U.S. pays the most for drugs compared to the rest of the world, usually about three times the amount …